Genetics of bronchopulmonary dysplasia: An update

Semin Perinatol. 2023 Oct;47(6):151811. doi: 10.1016/j.semperi.2023.151811. Epub 2023 Sep 9.

Abstract

Bronchopulmonary dysplasia (BPD) is a multi-factorial disease that results from multiple clinical factors, including lung immaturity, mechanical ventilation, oxidative stress, pulmonary congestion due to increasing cardiac blood shunting, nutritional and immunological factors. Twin studies have indicated that susceptibility to BPD can be strongly inherited in some settings. Studies have reported associations between common genetic variants and BPD in preterm infants. Recent genomic studies have highlighted a potential role for molecular pathways involved in inflammation and lung development in affected infants. Rare mutations in genes encoding the lipid transporter ATP-binding cassette, sub-family A, member 3 (ABCA3 gene) which is involved in surfactant synthesis in alveolar type II cells, as well as surfactant protein B (SFTPB) and C (SFTPC) can also result in severe form of neonatal-onset interstitial lung diseases and may also potentially affect the course of BPD. This chapter summarizes the current state of knowledge on the genetics of BPD.

Keywords: ATP-binding cassette; Bronchopulmonary dysplasia; Gene expression; Genetics; Infant; Member 3; Premature; Sub-family A; Surfactant proteins.

MeSH terms

  • Bronchopulmonary Dysplasia* / genetics
  • Humans
  • Infant
  • Infant, Newborn
  • Infant, Premature
  • Lung
  • Lung Diseases, Interstitial* / genetics
  • Lung Diseases, Interstitial* / metabolism
  • Surface-Active Agents

Substances

  • Surface-Active Agents